EBITDA

A partnership between myTomorrows and Rare Disease Research uses AI to streamline patient access to critical studies, offering new hope for families.

From $1,300 DIY setups to $100K+ labs, a new guide offers a crucial roadmap for researchers navigating the complex, costly world of VR investment.

A new clinical trial validates the Leva Pelvic Health System, offering a discreet, effective at-home treatment for a condition affecting millions of women.

With a massively oversubscribed €600M hybrid note offering, plant-based leader Roquette secures major funding and a huge vote of investor confidence.

A novel immunotherapy tames a potent but toxic cancer-fighting agent by locking it inside tumors, offering new hope for patients with resistant cancers.

As dating app fatigue grows and traditional matchmaking costs soar 26%, a new breed of affordable, human-led services is gaining traction with singles.

Quintara Biosciences launches AmpValue, a $4.99 overnight sequencing service set to disrupt biotech by making advanced, full-length data accessible to all.

A New York conference aims to fix the fragmented US e-invoicing market, promising billions in savings and enhanced security for American businesses.

A Swiss startup claims its new system offers deterministic control over AI art, moving beyond ambiguous text prompts. Is this the future of creation?

A new AI platform is revolutionizing how pharma creates complex scientific videos, earning industry award recognition for its speed, savings, and compliance.

Uranium Royalty Corp. is acquiring Sweetwater Royalties, combining high-growth uranium assets with stable soda ash cash flow in a landmark transaction.

With the strategic hire of Karl Kohler as CRO, Mail Metrics signals a major push for European dominance in customer communications, eyeing a $1B valuation.

A new $15M contract funds PlanetiQ's advanced satellites, giving the U.S. Air Force an unprecedented strategic edge with next-generation weather data.

The employee benefits giant reports impressive margin growth and reaffirms its yearly goals, but looming regulatory changes in its key Brazilian market will test its resilience.

The AI data center market is set to explode past $120 billion, fueling a global tech race and confronting critical challenges in power and cooling.

Manchester Metropolitan University unveils a £1.27M immersive virtual hospital, set to revolutionize how the next generation of doctors and scientists are trained.

A new program helps heritage brands discreetly adopt AI, enhancing exclusivity and operations behind the scenes without compromising their coveted identity.

With founder Frédéric Mascha as Executive Chairman and new CEO Renaud Sermondade, Juvisé Pharmaceuticals is poised for major M&A-fueled global expansion.

Bizzdesign's new AI-native platform, Unify, aims to end 'tool sprawl' by linking visual collaboration with live enterprise architecture data for all teams.

Inventia Life Science's new RASTRUM Validated Solutions offer standardized 3D models to tackle the reproducibility crisis in pharmaceutical R&D.